Featured Network Trials

LCCC1028 Title: Neoadjuvant Pazopanib: A Phase II Study to Evaluate the Effect on Disease Response and Recurrence and to Establish Predictive Biomarkers of Drug Activity in Renal Cell Carcinoma

PI, Kim Rathmell    Affiliate Coordinator, Donna Rowe, Telephone:  (919) 966-2152 or
LCCC1029 Title: Multi-Center, Randomized Placebo-Controlled Phase II Study of Regorafenib in Combination with FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) versus Placebo and FOLFIRI as Second Line Therapy in Patients with Metastatic Colorectal Cancer

PI, Bert O’Neil   Affiliate Coordinator, Maureen Tynan, Telephone,   919-966-7359 or EMAIL.

LCCC1025 Title: A Phase II Study Evaluating the Efficacy And Tolerability Of Everolimus (RAD001) In Combination With Trastuzumab And Vinorelbine In The Treatment Of Progressive HER2-Positive Breast Cancer Brain Metastases

PI, Carey Anders   Affiliate Coordinator, Donna Rowe, Telephone:  (919) 966-2152 or